Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study-Reference-Cited by-同舟云学术

Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study

Published:2003-01 Issue:5 Volume:19 Page:383-394
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Hosking David,Adami Silvano,Felsenberg Dieter,Andia Jorge Cannata,Välimäki Matti,Benhamou Laurent,Reginster Jean-Yves,Yacik Carol,Rybak-Feglin Andrea,Petruschke Richard A.,Zaru Luna,Santora Arthur C.

Publisher

Informa Healthcare

Subject

General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1185/030079903125002009

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials;BMJ;2023-05-02

2. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools;Systematic Reviews;2023-03-21

3. Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice;Osteoporosis International;2023-01-04

4. ¿(No) “solo Madrid es Corte”?: la cabeza que gobierna un imperio de Cortes;Culture & History Digital Journal;2022-06-21

5. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women;Cochrane Database of Systematic Reviews;2022-05-03